RBFOX1 and schizoaffective disorder: Finally, the levels of cytoplasmic (Fig. 3D), nuclear or total Rbfox1 (Supplementary Fig. 2) did not significantly differ as a function of a diagnosis of schizoaffective disorder; the presence of a substance use disorder at time of death; use of nicotine, antidepressants, benzodiazepines, or valproic acid at the time of death; or death by suicide.